At the news
? BEARISHIMPACT 8/10 PRESS-RELEASE filed May 6, 2026 at 07:30 ET
Medline reported Q1 2026 GAAP EPS of $0.01, a 96.6% miss vs consensus of $0.29, and net income fell 25.8% YoY to $239M. Revenue beat at $7.4B (+10.7% YoY) vs $7.16B consensus, and the company raised full-year organic sales guidance to 8.5%-9.5%. However, the massive EPS miss, declining margins (gross margin 25.0% vs 27.5% YoY), and operating cash flow drop of 39.6% overshadow the top-line beat.
- GAAP diluted EPS of $0.01 vs consensus $0.29, a 96.6% miss
- Net income fell 25.8% YoY to $239M; net income margin compressed to 3.3% from 4.8%
- Revenue of $7.4B beat consensus of $7.16B (+10.7% YoY)
- Gross margin declined 250 bps to 25.0% from 27.5% due to tariff impact and higher COGS
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access